FDA/USDA Regulations - Biotech/Drug Laws

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers. The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant.

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis. Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries. Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Date	Title	Organization
28 Oct	The Road Ahead – Four (4) “Mile Markers” to Watch in the Year Ahead	Stark & Stark
28 Oct	Cannabis and the Workplace: New York DOL Clears the Smoke with New Guidance	Greenberg Traurig, LLP
28 Oct	FDA Evaluates Asbestos in Cosmetics	Keller and Heckman LLP
27 Oct	Court Approves Settlement with HelloFresh Over Alleged TCPA Violations	Hunton Andrews Kurth
27 Oct	Key Legal Considerations Relating to Ketamine Behavioral Health Platforms	Proskauer Rose LLP
27 Oct	Calls for USPTO to Adopt Policies to Modulate Drug Pricing	Proskauer Rose LLP
27 Oct	New York Department of Labor Issues Guidance on Cannabis and the Workplace	Proskauer Rose LLP
27 Oct	Hard Seltzer Co. Sued for Overstating Health Benefits	Keller and Heckman LLP
26 Oct	EPA Announces Revisions to Guidance to Ensure Effectiveness of Antimicrobial Pesticides Against Candida Auris	Bergeson & Campbell, P.C.
26 Oct	FDA Convenes Medical Device Workshop Focused on Artificial Intelligence and Machine Learning Transparency	Nelson Mullins
26 Oct	FDA Withdraws Temporary Hand Sanitizer Policies	Keller and Heckman LLP
26 Oct	FDA Calls for Repeating Clinical and Bioanalytical Studies	Foley & Lardner LLP
25 Oct	New Details on China’s Overseas Food Facility Registration	Keller and Heckman LLP
25 Oct	AB-45: California Finally Welcomes Hemp Products To The Marketplace	Sheppard, Mullin, Richter & Hampton LLP
24 Oct	CBP Issues Withhold Release Order on Tomatoes Produced by Farm in Mexico	U.S. Customs and Border Protection
22 Oct	UK REACH Update: Imminent Deadlines And Challenges	McDermott Will & Emery
22 Oct	Tootsie Roll Dodges Another “Slack-Fill” Lawsuit	Keller and Heckman LLP
22 Oct	ESG and Emerging Contaminants – Investors Beware	CMBG3 Law
22 Oct	FDA Announces Withdrawal of Temporary Guidance Documents Concerning Alcohol-Based Hand Sanitizer Products	Bergeson & Campbell, P.C.
21 Oct	China’s Overseas Food Facility Registration: Some Deadlines You Need to Know About	Keller and Heckman LLP